IRREVOCABLE AGREEMENT TO CONVERT SERIES B CONVERTIBLE PREFERRED STOCKIrrevocable Agreement to Convert Series B Convertible Preferred Stock • February 3rd, 2006 • Neorx Corp • In vitro & in vivo diagnostic substances • Washington
Contract Type FiledFebruary 3rd, 2006 Company Industry JurisdictionThis Irrevocable Agreement to Convert Series B Convertible Preferred Stock (the “Agreement”) is made as of February 1, 2006 by and among NeoRx Corporation, a Washington corporation (the “Company”), the holders of shares of Series B Convertible Preferred Stock listed on Exhibit A attached hereto (individually, a “Preferred Holder” and collectively, the “Preferred Holders”) and the Purchasers (as defined below).